Euphrates Vascular was recently featured in Endovascular Today. The article, “Euphrates Vascular’s Ichor Reperfusion System Cleared by FDA,” discusses how the newly-approved Ichor system targets vascular occlusions by eliminating the need for surgery or drug therapies.
- Euphrates Vascular received FDA 510(k) clearance for the sale of its Ichor percutaneous reperfusion system, which is designed to treat organized thrombus and embolic events in the peripheral vasculature.
- Ichor is a one-size-fits-all system that replicates the standard of care of surgical embolectomy/thrombectomy but in a minimally invasive manner.
- “Ichor will be an extraordinary tool in the clot management toolbox due to its ability to handle the organized clot many physicians struggle to treat,” said Troy Long, MD.